M. Eileen Dolan

3.3k total citations · 1 hit paper
27 papers, 2.4k citations indexed

About

M. Eileen Dolan is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, M. Eileen Dolan has authored 27 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Genetics. Recurrent topics in M. Eileen Dolan's work include DNA Repair Mechanisms (3 papers), RNA and protein synthesis mechanisms (3 papers) and Lung Cancer Research Studies (3 papers). M. Eileen Dolan is often cited by papers focused on DNA Repair Mechanisms (3 papers), RNA and protein synthesis mechanisms (3 papers) and Lung Cancer Research Studies (3 papers). M. Eileen Dolan collaborates with scholars based in United States, China and Australia. M. Eileen Dolan's co-authors include Cara A. Rabik, Jerry B. Dodgson, James Douglas Engel, Zhen Zhao, Timothy S. Pardee, Amy Rappaport, Mila E. McCurrach, Johannes Zuber, Scott C. Kogan and Scott W. Lowe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

M. Eileen Dolan

27 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular mechanisms of resistance and toxicity associated with platinating agents

2006 1.3k citations Cara A. Rabik, M. Eileen Dolan Cancer Treatment Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Eileen Dolan United States	18	1.3k	850	304	291	231	27	2.4k
Mark R. Bray Canada	27	1.6k 1.2×	754 0.9×	213 0.7×	345 1.2×	208 0.9×	65	2.7k
Michelle A. Blaskovich United States	27	1.9k 1.4×	1.4k 1.6×	454 1.5×	360 1.2×	315 1.4×	44	3.3k
Michael J. Tilby United Kingdom	24	1.3k 1.0×	661 0.8×	245 0.8×	236 0.8×	135 0.6×	55	2.0k
Jürgen Thomale Germany	29	1.7k 1.3×	765 0.9×	211 0.7×	558 1.9×	275 1.2×	76	2.8k
Akihiro Tomida Japan	35	2.3k 1.7×	929 1.1×	254 0.8×	686 2.4×	107 0.5×	99	3.6k
Hidenori Nakajima Japan	22	2.9k 2.1×	589 0.7×	504 1.7×	290 1.0×	134 0.6×	45	3.6k
Yi Lisa Lyu United States	23	2.0k 1.5×	1.5k 1.7×	280 0.9×	204 0.7×	266 1.2×	33	3.7k
Maja Osmak Croatia	24	1.2k 0.9×	740 0.9×	376 1.2×	372 1.3×	230 1.0×	115	2.4k
Howard L. Elford United States	26	1.2k 0.9×	708 0.8×	279 0.9×	188 0.6×	79 0.3×	76	2.4k
Angelica M. Merlot Australia	21	1.0k 0.7×	631 0.7×	255 0.8×	185 0.6×	144 0.6×	24	2.2k

Countries citing papers authored by M. Eileen Dolan

Since Specialization

Citations

This map shows the geographic impact of M. Eileen Dolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Eileen Dolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Eileen Dolan more than expected).

Fields of papers citing papers by M. Eileen Dolan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Eileen Dolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Eileen Dolan. The network helps show where M. Eileen Dolan may publish in the future.

Co-authorship network of co-authors of M. Eileen Dolan

This figure shows the co-authorship network connecting the top 25 collaborators of M. Eileen Dolan. A scholar is included among the top collaborators of M. Eileen Dolan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Eileen Dolan. M. Eileen Dolan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Hai, Jill L. Reiter, Yue Wang, et al.. (2019). RegSNPs-intron: a computational framework for predicting pathogenic impact of intronic single nucleotide variants. Genome biology. 20(1). 254–254. 41 indexed citations

Travis, Lois B., Sophie D. Fosså, Howard D. Sesso, et al.. (2014). Chemotherapy-Induced Peripheral Neurotoxicity and Ototoxicity: New Paradigms for Translational Genomics. JNCI Journal of the National Cancer Institute. 106(5). dju044–dju044. 93 indexed citations

Gamazon, Eric R., R. Stephanie Huang, M. Eileen Dolan, Nancy J. Cox, & Hae Kyung Im. (2013). Integrative Genomics: Quantifying Significance of Phenotype-Genotype Relationships from Multiple Sources of High-Throughput Data. Frontiers in Genetics. 3. 202–202. 11 indexed citations

Ko, Dennis C., Eric R. Gamazon, Richard A. Pfuetzner, et al.. (2012). Functional genetic screen of human diversity reveals that a methionine salvage enzyme regulates inflammatory cell death. Proceedings of the National Academy of Sciences. 109(35). E2343–52. 43 indexed citations

Zuber, Johannes, Ina Radtke, Timothy S. Pardee, et al.. (2009). Mouse models of human AML accurately predict chemotherapy response. Genes & Development. 23(7). 877–889. 201 indexed citations

Bleibel, Wasim K., Shiwei Duan, R. Stephanie Huang, et al.. (2008). Identification of genomic regions contributing to etoposide-induced cytotoxicity. Human Genetics. 125(2). 173–180. 43 indexed citations

Zhang, Wei, Shiwei Duan, Emily O. Kistner, et al.. (2008). Evaluation of Genetic Variation Contributing to Differences in Gene Expression between Populations. The American Journal of Human Genetics. 82(5). 1223–1223. 5 indexed citations

Rabik, Cara A., Melissa L. Fishel, Julianne L. Holleran, et al.. (2008). Enhancement of Cisplatin [cis-Diammine Dichloroplatinum (II)] Cytotoxicity by O6-Benzylguanine Involves Endoplasmic Reticulum Stress. Journal of Pharmacology and Experimental Therapeutics. 327(2). 442–452. 33 indexed citations

Rabik, Cara A., et al.. (2008). Role of copper transporters in resistance to platinating agents. Cancer Chemotherapy and Pharmacology. 64(1). 133–142. 36 indexed citations

10.

Yamini, Bakhtiar, Xiaohong Yu, M. Eileen Dolan, et al.. (2007). Inhibition of Nuclear Factor-κB Activity by Temozolomide Involves O 6-Methylguanine–Induced Inhibition of p65 DNA Binding. Cancer Research. 67(14). 6889–6898. 33 indexed citations

11.

Rabik, Cara A. & M. Eileen Dolan. (2006). Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treatment Reviews. 33(1). 9–23. 1321 indexed citations breakdown →

12.

Dolan, M. Eileen, et al.. (2003). Temozolomide: realizing the promise and potential. Current Opinion in Oncology. 15(6). 412–418. 32 indexed citations

13.

Nagasubramanian, Ramamoorthy & M. Eileen Dolan. (2003). Pharmacogenomics – Racing Towards Personalized Prescriptions. Laboratory Medicine. 34(9). 651–659. 2 indexed citations

14.

Park, Dongsu, Charles J. Ryan, M. Eileen Dolan, N. Vogelzang, & Walter M. Stadler. (2002). A phase II trial of oral temozolomide in patients with metastatic renal cell cancer. Cancer Chemotherapy and Pharmacology. 50(2). 160–162. 15 indexed citations

15.

Gamcsik, Michael P., M. Eileen Dolan, Börje S. Andersson, & David J. Murray. (1999). Mechanisms of Resistance to the Toxicity of Cyclophosphamide. Current Pharmaceutical Design. 5(8). 587–605. 56 indexed citations

16.

Zagaja, Gregory P., et al.. (1998). Effects of polyamine analogues on prostatic adenocarcinoma cells in vitro and in vivo. Cancer Chemotherapy and Pharmacology. 41(6). 505–512. 28 indexed citations

17.

Zachgo, Eve Ann, Julia Dewdney, David Bouchez, et al.. (1996). A physical map of chromosome 2 of Arabidopsis thaliana.. Genome Research. 6(1). 19–25. 82 indexed citations

18.

Margulis, Lynn, et al.. (1996). Diversity of eukaryotic microorganisms: computer-based resources, "The Handbook of Protoctista" and its "Glossary".. PubMed. 12(1). 29–42. 3 indexed citations

19.

Dolan, M. Eileen, et al.. (1995). Large-scale genomic sequencing: optimization of genomic chemical sequencing reactions.. PubMed. 19(2). 264–8, 270. 3 indexed citations

20.

Dolan, M. Eileen, Anthony E. Pegg, Luba Dumenco, Robert C. Moschel, & Stanton L. Gerson. (1991). Comparison of the inactivation of mammalian and bacterial O⁶-alkylguanine-DNA alkyltransferases by O⁶-benzylguanine and O⁶-methylguanine. Carcinogenesis. 12(12). 2305–2309. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact